[Federal Register Volume 86, Number 221 (Friday, November 19, 2021)]
[Notices]
[Pages 64953-64954]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-25209]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of the Secretary; Notice of Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the Muscular Dystrophy 
Coordinating Committee (MDCC).
    The meeting will be open to the public. Individuals who plan to 
participate and need special assistance, such as sign language 
interpretation or other reasonable accommodations, should notify the 
Contact Person listed below in advance of the meeting.

    Name of Committee: Muscular Dystrophy Coordinating Committee.
    Date: December 20, 2021.
    Time: 1:00 p.m. to 5:00 p.m. EST
    Agenda: The purpose of this meeting is to bring together 
committee members, representing government agencies, patient 
advocacy groups, other voluntary health

[[Page 64954]]

organizations, and patients and their families to update one another 
on progress relevant to the Action Plan for the Muscular Dystrophies 
and to coordinate activities and discuss gaps and opportunities 
leading to better understanding of the muscular dystrophies, 
advances in treatments, and improvements in patients' and their 
families' lives. The agenda for this meeting is available on the 
MDCC website: https://www.mdcc.nih.gov/.
    Registration: To register, please go to: https://roseliassociates.zoomgov.com/webinar/register/WN_E2_Swp8wQjWtnZFgls2YCg.
    Webcast Live: https://videocast.nih.gov/.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Blvd., Bethesda, MD 20892, (Virtual Meeting).
    Contact Person: Glen Nuckolls, Ph.D., Program Director, National 
Institute of Neurological Disorders and Stroke (NINDS), NIH, 6001 
Executive Blvd., Rm. 2203, Bethesda, MD 20892, 301-496-5876, 
[email protected].

    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    More information can be found on the Muscular Dystrophy 
Coordinating Committee home page: https://mdcc.nih.gov/.

    Dated: November 15, 2021.
David W Freeman,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-25209 Filed 11-18-21; 8:45 am]
BILLING CODE 4140-01-P